Browsing by Author "Rantalainen T"
Now showing items 1-1 of 1
-
Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy
Puolakkainen T; Ma H; Kainulainen H; Pasternack A; Rantalainen T; Ritvos O; Heikinheimo O; Hulmi JJ; Kiviranta R (Springer Nature, 2017)Background Inhibition of activin/myostatin pathway has emerged as a novel approach to increase muscle mass and bone strength. Duchenne muscular dystrophy (DMD) is a neuromuscular disorder that leads to progressive muscle ...info:eu-repo/semantics/article